GG
BMY icon

Gofen & Glossberg’s Bristol-Myers Squibb BMY Stock Holding History

Gofen & Glossberg’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$6.83M Sell
94,923
-2,852
-3% -$215K 0.18% 117
2022
Q3 		$6.95M Buy
97,775
+174
+0.2% +$12.6K 0.2% 114
2022
Q2 		$7.51M Sell
97,601
-562
-0.6% -$42.8K 0.2% 111
2022
Q1 		$7.17M Sell
98,163
-3,280
-3% -$220K 0.16% 118
2021
Q4 		$6.33M Sell
101,443
-41,905
-29% -$2.46M 0.14% 127
2021
Q3 		$8.48M Sell
143,348
-2,599
-2% -$171K 0.2% 107
2021
Q2 		$9.75M Sell
145,947
-14,422
-9% -$940K 0.23% 97
2021
Q1 		$10.1M Sell
160,369
-19,937
-11% -$1.24M 0.26% 89
2020
Q4 		$11.2M Sell
180,306
-4,087
-2% -$251K 0.31% 80
2020
Q3 		$11.1M Buy
184,393
+9,029
+5% +$543K 0.34% 71
2020
Q2 		$10.3M Buy
175,364
+6,819
+4% +$408K 0.35% 72
2020
Q1 		$9.39M Sell
168,545
-8,760
-5% -$535K 0.37% 70
2019
Q4 		$11.4M Buy
177,305
+138,128
+353% +$7.91M 0.36% 71
2019
Q3 		$1.99M Sell
39,177
-1,119
-3% -$52.6K 0.07% 165
2019
Q2 		$1.83M Sell
40,296
-872
-2% -$40.6K 0.06% 169
2019
Q1 		$1.96M Sell
41,168
-590
-1% -$29.4K 0.07% 164
2018
Q4 		$2.17M Sell
41,758
-625
-1% -$33.6K 0.09% 150
2018
Q3 		$2.63M Sell
42,383
-989
-2% -$58.7K 0.09% 151
2018
Q2 		$2.4M Sell
43,372
-320
-0.7% -$17.3K 0.09% 152
2018
Q1 		$2.76M Sell
43,692
-1,280
-3% -$82.3K 0.1% 139
2017
Q4 		$2.76M Sell
44,972
-727
-2% -$45.5K 0.1% 144
2017
Q3 		$2.91M Sell
45,699
-123
-0.3% -$7.18K 0.11% 141
2017
Q2 		$2.55M Sell
45,822
-970
-2% -$52.8K 0.1% 150
2017
Q1 		$2.54M Sell
46,792
-151
-0.3% -$8.28K 0.1% 146
2016
Q4 		$2.74M Buy
46,943
+2,722
+6% +$149K 0.11% 135
2016
Q3 		$2.38M Buy
44,221
+1,252
+3% +$80.4K 0.1% 154
2016
Q2 		$3.16M Buy
42,969
+261
+0.6% +$18.4K 0.13% 125
2016
Q1 		$2.73M Sell
42,708
-485
-1% -$30.6K 0.12% 134
2015
Q4 		$2.97M Buy
43,193
+240
+0.6% +$15.9K 0.13% 129
2015
Q3 		$2.54M Buy
42,953
+2,043
+5% +$130K 0.12% 137
2015
Q2 		$2.72M Sell
40,910
-150
-0.4% -$9.88K 0.11% 140
2015
Q1 		$2.65M Sell
41,060
-375
-0.9% -$23.5K 0.11% 140
2014
Q4 		$2.45M Sell
41,435
-551
-1% -$31.1K 0.11% 151
2014
Q3 		$2.15M Sell
41,986
-2,042
-5% -$102K 0.09% 155
2014
Q2 		$2.14M Sell
44,028
-7,743
-15% -$382K 0.09% 158
2014
Q1 		$2.78M Buy
51,771
+12,517
+32% +$666K 0.13% 130
2013
Q4 		$2.09M Sell
39,254
-166
-0.4% -$8.46K 0.1% 155
2013
Q3 		$1.82M Sell
39,420
-207
-0.5% -$9.09K 0.09% 156
2013
Q2 		$1.77M Buy
+39,627
New +$1.72M 0.1% 157

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Gofen & Glossberg's BMY Position: Q4 2022 in Review

Gofen & Glossberg reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q4 2022, selling an estimated $215K and leaving 94,923 shares worth $6.83M. The position accounts for 0.18% of the portfolio, ranked #117.

Gofen & Glossberg first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $11.4M in Q4 2019. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Gofen & Glossberg held 94,923 shares of Bristol-Myers Squibb worth $6.83M as of Q4 2022.
  • Gofen & Glossberg sold 2,852 Bristol-Myers Squibb shares in Q4 2022, an estimated $215K.
  • Bristol-Myers Squibb made up 0.18% of Gofen & Glossberg's portfolio in Q4 2022, its #117 holding.
  • Gofen & Glossberg first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
  • Gofen & Glossberg's Bristol-Myers Squibb position peaked at $11.4M in Q4 2019.
  • 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.